Incidence of rheumatoid arthritis in Sweden: a nationwide population‐based assessment of incidence, its determinants, and treatment penetration
JK Eriksson, M Neovius, S Ernestam… - Arthritis care & …, 2013 - Wiley Online Library
Objective To estimate the nationwide incidence of rheumatoid arthritis (RA) in Sweden,
including its variation across age, sex, geography, and demography, and to describe the …
including its variation across age, sex, geography, and demography, and to describe the …
Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?
JK Eriksson, L Jacobsson, K Bengtsson… - Annals of the rheumatic …, 2017 - ard.bmj.com
Aims To assess and compare the incidence of cardiovascular (CV) events, by CV
phenotype, between patients with ankylosing spondylitis (AS), rheumatoid arthritis (RA) and …
phenotype, between patients with ankylosing spondylitis (AS), rheumatoid arthritis (RA) and …
Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort study
M Neovius, SH Jacobson, JK Eriksson, CG Elinder… - BMJ open, 2014 - bmjopen.bmj.com
Objective To compare mortality in chronic kidney disease (CKD) stages 4 and 5 (estimated
glomerular filtration rate< 30 mL/min/1.73 m2), peritoneal dialysis, haemodialysis and …
glomerular filtration rate< 30 mL/min/1.73 m2), peritoneal dialysis, haemodialysis and …
[HTML][HTML] The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study
S Exarchou, U Lindström, J Askling, JK Eriksson… - Arthritis research & …, 2015 - Springer
Introduction Prevalence estimates of ankylosing spondylitis vary considerably, and there are
few nationwide estimates. The present study aimed to describe the national prevalence of …
few nationwide estimates. The present study aimed to describe the national prevalence of …
Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden
JK Eriksson, M Neovius, SH Jacobson, CG Elinder… - BMJ open, 2016 - bmjopen.bmj.com
Objective To compare healthcare costs in chronic kidney disease (CKD) stage 4 or 5 not on
dialysis (estimated glomerular filtration rate< 30 mL/min/1.73 m2), peritoneal dialysis …
dialysis (estimated glomerular filtration rate< 30 mL/min/1.73 m2), peritoneal dialysis …
Health-care costs over 15 years after bariatric surgery for patients with different baseline glucose status: results from the Swedish Obese Subjects study
Background Bariatric surgery prevents and induces remission of type 2 diabetes in many
patients. The effect of preoperative glucose status on long-term health-care costs is …
patients. The effect of preoperative glucose status on long-term health-care costs is …
[HTML][HTML] Validation of the rheumatoid arthritis diagnosis in the Swedish National Patient Register: a cohort study from Stockholm County
K Waldenlind, JK Eriksson, B Grewin… - BMC musculoskeletal …, 2014 - Springer
Abstract Background The Swedish National Patient Register offers unique possibilities for
identification of large cohorts, such as patients with rheumatoid arthritis (RA). Although the …
identification of large cohorts, such as patients with rheumatoid arthritis (RA). Although the …
Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?
JK Eriksson, K Johansson, J Askling… - Annals of the rheumatic …, 2015 - ard.bmj.com
Objective To estimate the costs related to hospital care, drug use and work loss in prevalent
and incident patients with rheumatoid arthritis (RA), and to describe their distribution …
and incident patients with rheumatoid arthritis (RA), and to describe their distribution …
Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort
T Olofsson, IF Petersson, JK Eriksson… - Annals of the …, 2014 - ard.bmj.com
Objective To identify predictors of sick leave and disability pension in patients with early
rheumatoid arthritis (RA). Methods Individuals aged 19–59 years diagnosed with early RA …
rheumatoid arthritis (RA). Methods Individuals aged 19–59 years diagnosed with early RA …
Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched …
JK Eriksson, JA Karlsson, J Bratt… - Annals of the …, 2015 - ard.bmj.com
Objective To estimate the incremental cost-effectiveness of infliximab versus conventional
combination treatment over 21 months in patients with methotrexate-refractory early …
combination treatment over 21 months in patients with methotrexate-refractory early …